US Cardiac Monitoring Devices Market - Size, Share, Segmentation, Regional Insights, Key Players & Forecast, 2026–2035

By 2035, the US Cardiac Monitoring Devices Market is projected to reach approximately USD 18.64 billion, expanding at a CAGR of 7.92% during the forecast period 2026–2035. The market was valued at USD 8.57 billion in 2025, with historical analysis conducted from 2021 to 2024.

Cardiovascular disease remains the leading cause of death in the United States, accounting for nearly one in every five deaths annually. Rising prevalence of arrhythmias, atrial fibrillation (AFib), heart failure, and ischemic heart disease continues to create strong demand for continuous and remote cardiac monitoring technologies. As healthcare systems transition toward value-based care and preventive cardiology models, cardiac monitoring devices are increasingly becoming essential clinical tools rather than optional diagnostics.

Technological advancement is reshaping the cardiac monitoring landscape. Portable telemetry systems, wearable ECG monitors, implantable loop recorders, mobile cardiac outpatient telemetry (MCOT) devices, and AI-enabled rhythm detection software are transforming how cardiologists and electrophysiologists manage patients. Remote patient monitoring (RPM) reimbursement policies under CMS have further accelerated adoption across hospital systems and outpatient cardiac centers.

The US benefits from a mature reimbursement environment, high diagnostic procedure volumes, and widespread digital health integration, positioning it as one of the most technologically advanced cardiac monitoring markets globally.

Introduction

According to the US Cardiac Monitoring Devices Market Report, demand growth is shaped by the increasing burden of cardiovascular disease, aging demographics, expanding remote monitoring programs, and technological convergence between medical devices and digital health platforms.

The United States records over 805,000 heart attacks annually and millions of arrhythmia diagnoses each year. Atrial fibrillation alone affects more than 6 million Americans, and this number is projected to increase significantly over the next decade. Continuous cardiac monitoring plays a vital role in early detection, stroke prevention, post-procedural follow-up, and chronic disease management.

The integration of cloud-based analytics, AI-driven arrhythmia detection, wearable biosensors, and smartphone-compatible ECG solutions has accelerated diagnostic efficiency. Healthcare providers are prioritizing early intervention models that rely on continuous rhythm monitoring to reduce emergency admissions and readmissions, particularly for heart failure and arrhythmia patients.

Key Market Drivers: What’s Fueling the US Cardiac Monitoring Devices Market Boom?

• Rising Prevalence of Arrhythmias and Atrial Fibrillation
  Atrial fibrillation cases in the US are projected to exceed 12 million by 2030. Early detection through ambulatory ECG monitoring, patch-based systems, and implantable loop recorders significantly reduces stroke risk. As clinical guidelines emphasize proactive rhythm management, device adoption continues to expand.
• Growing Geriatric Population
  By 2030, more than 20% of the US population will be aged 65 or older. Cardiovascular risk rises significantly with age, leading to higher demand for continuous cardiac monitoring in both hospital and home-care settings.
• Expansion of Remote Patient Monitoring (RPM) Reimbursement
  CMS reimbursement codes for remote cardiac monitoring have significantly accelerated device utilization. Healthcare providers can now receive structured reimbursement for remote rhythm monitoring, enabling faster integration into cardiology practices.
• Shift Toward Outpatient and Home-Based Care
  Ambulatory surgical centers and home healthcare providers are increasingly deploying wireless and wearable ECG devices. Reduced hospital stays and post-procedural monitoring programs further drive market growth.

Innovation in Focus: How Manufacturers Are Raising the Bar?

Device manufacturers are investing in AI-based arrhythmia classification algorithms, real-time cloud data synchronization, extended battery life, and patient-friendly wearable formats. Patch-based ECG monitors now allow up to 14–30 days of uninterrupted monitoring. Implantable cardiac monitors offer multi-year surveillance capabilities for cryptogenic stroke patients.

Smartwatch-integrated ECG monitoring has introduced consumer-driven cardiac screening, expanding patient engagement. Machine learning systems are now capable of detecting subtle rhythm abnormalities, improving sensitivity while reducing false positives.

Cybersecurity compliance, HIPAA-aligned cloud platforms, and EHR integration capabilities are becoming core differentiators among leading US manufacturers.

Recent Developments

AI-enabled arrhythmia detection tools have improved diagnostic yield across ambulatory monitoring platforms. Expansion of CMS reimbursement codes for RPM services continues to drive outpatient adoption. Patch-based ECG technologies are increasingly replacing traditional Holter monitors due to comfort and extended wear time.

Major hospital systems are integrating cloud-based cardiac telemetry into enterprise EHR systems to enable real-time cardiology review.

Conclusion

The US Cardiac Monitoring Devices Market Size & Share continues to expand as cardiovascular disease prevalence, remote patient monitoring adoption, and technological innovation converge. Implantable and wearable monitoring systems are transforming preventive cardiology. With favorable reimbursement, strong hospital infrastructure, and high digital health integration, the US market is positioned for sustainable long-term growth through 2035.

The US Cardiac Monitoring Devices Market is moderately consolidated with strong competition among global device manufacturers and digital health innovators.

• Medtronic plc – Leader in implantable loop recorders and remote cardiac monitoring systems with strong US hospital penetration.
• Abbott Laboratories – Offers Confirm Rx insertable monitors and advanced ECG solutions widely used in US cardiology practices.
• Boston Scientific Corporation – Expanding cardiac rhythm management portfolio across US electrophysiology centers.
• Philips Healthcare – Strong presence in hospital-based telemetry and ECG systems.
• GE HealthCare – Dominant in hospital ECG and monitoring platforms nationwide.
• iRhythm Technologies – US-based leader in patch-based ambulatory ECG monitoring (Zio platform).
• BioTelemetry (Philips subsidiary) – Major MCOT provider across US cardiology clinics.
• AliveCor – Consumer and clinical-grade smartphone ECG leader.
• Hillrom (Baxter) – Telemetry and hospital monitoring systems.
• Biotronik – Implantable monitoring systems across electrophysiology labs.
• Cardiac Insight – Wearable ECG platform innovator.
• Preventice Solutions (Boston Scientific) – Remote cardiac monitoring provider.
• VectraCor – ECG diagnostic technology developer.
• Bittium – Advanced ambulatory ECG systems.
• Nihon Kohden America – Clinical ECG systems supplier.
• MicroPort CRM – Cardiac rhythm management solutions.
• Qardio – Consumer heart monitoring solutions.
• Lepu Medical – Expanding US presence.
• ZOLL Medical – Cardiac monitoring and emergency solutions.
• Schiller Americas – Diagnostic ECG systems.
• Spacelabs Healthcare – Telemetry and monitoring systems.
• Masimo – Advanced biosensor technologies integrated into monitoring devices.
• Garmin Health – Wearable cardiac health tracking.
• Withings – Consumer-grade ECG monitoring devices.

• Resting ECG Systems
  Widely used in hospitals and primary care settings, resting ECG systems remain essential for routine cardiac assessment. Adoption is steady across outpatient clinics and emergency departments.
• Holter Monitors
  Holter monitors continue to serve as a gold standard for short-term ambulatory ECG monitoring. Demand remains strong in cardiology practices and diagnostic centers.
• Event Monitors
  Event monitors are gaining traction for intermittent arrhythmia detection. Their cost-effectiveness makes them widely used in outpatient care.
• Implantable Loop Recorders (ILRs)
  Implantable monitors represent one of the fastest-growing segments, driven by stroke prevention protocols and cryptogenic stroke management.
• Mobile Cardiac Telemetry (MCOT)
  MCOT devices are expanding rapidly due to real-time rhythm transmission capabilities and improved diagnostic accuracy.
• Wearable ECG & Patch Monitors
  This segment is witnessing the fastest growth due to patient comfort, long wear time, and digital connectivity.

• Portable Monitoring Devices
  Portable devices dominate the market due to convenience, outpatient compatibility, and RPM alignment.
• Implantable Monitoring Devices
  Implantable devices are growing steadily, particularly in high-risk arrhythmia and stroke patients.

• Arrhythmia Monitoring
  The dominant application segment, accounting for the majority of device usage nationwide.
• Heart Failure Monitoring
  Increasing adoption of continuous cardiac telemetry supports early decompensation detection.
• Ischemic Heart Disease Monitoring
  Monitoring systems assist in post-myocardial infarction management.
• Post-Surgical Cardiac Monitoring
  Used widely after cardiac ablation and valve procedures.

• Hospitals
  Hospitals remain the largest end-user segment, particularly for inpatient telemetry and diagnostic ECG.
• Cardiology Clinics
  Private cardiology practices represent a strong growth segment driven by outpatient diagnostics.
• Ambulatory Surgical Centers
  ASC utilization is rising due to cost-efficient cardiac procedure monitoring.
• Home Healthcare Settings
  The fastest-growing segment, supported by remote patient monitoring reimbursement and aging population trends.

West Region
The West leads the market due to strong technology adoption, digital health integration, and concentration of innovative healthcare systems.

• California
  California dominates nationally, driven by large hospital networks such as Kaiser Permanente and UCLA Health. High AFib prevalence and advanced RPM adoption fuel growth.
• Washington
  Seattle’s technology-driven healthcare ecosystem supports strong wearable ECG adoption.
• Colorado
  Strong outpatient cardiology infrastructure supports ambulatory ECG expansion.
• Arizona
  Retirement communities increase demand for remote cardiac monitoring.
• Oregon
  Growing investment in telehealth supports device integration.
• Other states including Nevada, Utah, Idaho, Montana, Wyoming, Alaska, and Hawaii show steady growth driven by rural RPM initiatives.

Northeast Region
Academic hospitals and advanced electrophysiology centers drive growth.

• New York
  New York remains a major cardiac diagnostics hub with high arrhythmia procedure volumes.
• Massachusetts
  Boston-based academic medical centers are early adopters of implantable monitoring systems.
• New Jersey
  Strong outpatient cardiac centers support ambulatory ECG usage.
• Pennsylvania
  High cardiovascular disease burden drives consistent device demand.
• Connecticut
  Integrated health systems promote telemetry adoption.

South Region
The South shows the fastest growth rate due to rising cardiovascular disease prevalence.

• Texas
  Texas is one of the largest state markets due to population size and expanding hospital networks.
• Florida
  High elderly population drives wearable ECG adoption.
• Georgia
  Atlanta’s cardiology centers show strong MCOT usage.
• North Carolina
  Research Triangle health systems support innovation adoption.
• Tennessee
  Cardiology practices are expanding remote monitoring programs.
• States including Alabama, South Carolina, Mississippi, Louisiana, Kentucky, Arkansas, Oklahoma, Virginia, Maryland, and West Virginia are witnessing increasing RPM reimbursement utilization.

Midwest Region
Midwestern states show steady adoption aligned with hospital system modernization.

• Illinois
  Chicago’s advanced cardiac centers support high telemetry usage.
• Ohio
  Large hospital systems are integrating AI-enabled ECG analytics.
• Michigan
  Growing heart failure patient base increases monitoring demand.
• Minnesota
  Home to major device manufacturers, supporting strong adoption.
• Indiana, Wisconsin, Missouri
  Moderate but steady growth driven by outpatient cardiology.
• Other states including Iowa, Kansas, Nebraska, North Dakota, and South Dakota are integrating rural telecardiology initiatives.

1. US Cardiac Monitoring Devices Market: Market Introduction & Context

1.1 Market Definition
1.2 Scope of the Study
1.3 Research Methodology
1.3.1 Primary Data Collection
1.3.2 Secondary Data Sourcing
1.3.3 External Industry Collaborations
1.3.4 In-House Research Databases
1.3.5 Analytical Frameworks & Forecasting Models
1.3.6 Data Validation and Final Report Publishing
1.4 Key Assumptions
1.5 Market Ecosystem Overview
1.6 Stakeholder Analysis (Manufacturers, Suppliers, Distributors, Healthcare Providers, Payers, Patients)
What this section provides: Introduces the report’s scope, methodology, validation processes, assumptions, and ecosystem mapping to ensure transparency and research reliability.

2. US Cardiac Monitoring Devices Market: Executive Summary

2.1 Key Insights & Market Snapshot (2025)
2.2 Analyst Viewpoint
2.3 Market Attractiveness Index
2.4 Strategic Highlights
What this section provides: Offers a concise overview of market size, CAGR (2026–2035), major growth trends, and strategic investment pockets.

3. US Cardiac Monitoring Devices Market: Market Dynamics & Outlook

3.1 Drivers and Their Impact Analysis
3.2 Restraints and Their Impact Analysis
3.3 Opportunities and Their Impact Analysis
3.4 Patent & Innovation Analysis (2020–2025)
What this section provides: Evaluates growth accelerators such as rising arrhythmia prevalence, RPM reimbursement expansion, digital health integration, and outlines potential risks and regulatory constraints.

4. US Cardiac Monitoring Devices Market: Market Environment & Industry Analysis

4.1 PESTEL Analysis
4.1.1 Political
4.1.2 Economic
4.1.3 Social
4.1.4 Technological
4.1.5 Environmental
4.1.6 Legal
4.2 Porter’s Five Forces Analysis
4.2.1 Threat of New Entrants
4.2.2 Bargaining Power of Buyers
4.2.3 Bargaining Power of Suppliers
4.2.4 Substitution Risk
4.2.5 Competitive Rivalry
4.3 Pricing Trend Analysis by Region (2024–2030)
4.4 Value Chain & Supply Chain Analysis
4.5 Impact of Digitalization & AI in Cardiac Monitoring
4.6 Regulatory Framework Analysis (FDA, CMS, RPM Reimbursement Codes)
4.7 Import/Export Restrictions & Tariff Impact
4.8 Government Initiatives
4.9 Impact of Escalating Geopolitical Tensions
What this section provides: Comprehensive macro and micro-environment analysis, regulatory landscape, competitive forces, and digital transformation impact.

5. US Cardiac Monitoring Devices Market – By Product Type

5.1 Overview
5.2 Segment Share Analysis, By Product Type, 2025 & 2035 (%)
5.2.1 Resting ECG Systems
5.2.2 Stress ECG Systems
5.2.3 Holter Monitors
5.2.4 Event Monitors
5.2.5 Implantable Loop Recorders (ILRs)
5.2.6 Mobile Cardiac Telemetry (MCOT)
5.2.7 Wearable ECG & Patch Monitors
What this section provides: Identifies product categories driving revenue growth and technological transformation.

6. US Cardiac Monitoring Devices Market – By Modality

6.1 Overview
6.2 Segment Share Analysis, By Modality, 2025 & 2035 (%)
6.2.1 Portable Monitoring Devices
6.2.2 Implantable Monitoring Devices
6.2.3 Remote & Cloud-Based Monitoring Platforms
What this section provides: Highlights delivery formats and remote monitoring evolution shaping patient care models.

7. US Cardiac Monitoring Devices Market – By Application

7.1 Overview
7.2 Segment Share Analysis, By Application, 2025 & 2035 (%)
7.2.1 Arrhythmia Monitoring
7.2.2 Atrial Fibrillation Management
7.2.3 Heart Failure Monitoring
7.2.4 Post-Operative Cardiac Monitoring
7.2.5 Ischemic Heart Disease Monitoring
What this section provides: Breaks down disease-specific demand and clinical adoption areas.

8. US Cardiac Monitoring Devices Market – By End-User

8.1 Overview
8.2 Segment Share Analysis, By End-User, 2025 & 2035 (%)
8.2.1 Hospitals
8.2.2 Cardiology Clinics
8.2.3 Ambulatory Surgical Centers
8.2.4 Diagnostic Centers
8.2.5 Home Healthcare Settings
What this section provides: Identifies primary revenue-generating healthcare settings and RPM expansion trends.

9. US Cardiac Monitoring Devices Market – By Geography

9.1 Introduction
9.2 Segment Share Analysis, By Geography, 2025 & 2035 (%)
9.3 West Region
9.3.1 Regional Overview & Trends
9.3.2 West Region Market Size & Forecast, By State, 2025–2035
9.3.2.1 California
9.3.2.2 Washington
9.3.2.3 Colorado
9.3.2.4 Arizona
9.3.2.5 Oregon
9.3.2.6 Nevada
9.3.2.7 Utah
9.3.2.8 New Mexico
9.3.2.9 Idaho
9.3.2.10 Montana
9.3.2.11 Wyoming
9.3.2.12 Alaska
9.3.2.13 Hawaii
9.4 Northeast Region
9.4.1 Regional Overview & Trends
9.4.2 Northeast Market Size & Forecast, By State
9.4.2.1 New York
9.4.2.2 Massachusetts
9.4.2.3 New Jersey
9.4.2.4 Pennsylvania
9.4.2.5 Connecticut
9.4.2.6 Maine
9.4.2.7 Vermont
9.4.2.8 New Hampshire
9.4.2.9 Rhode Island
9.4.2.10 Delaware
9.5 South Region
9.5.1 Regional Overview & Trends
9.5.2 South Market Size & Forecast, By State
9.5.2.1 Texas
9.5.2.2 Florida
9.5.2.3 Georgia
9.5.2.4 North Carolina
9.5.2.5 Tennessee
9.5.2.6 South Carolina
9.5.2.7 Alabama
9.5.2.8 Mississippi
9.5.2.9 Louisiana
9.5.2.10 Arkansas
9.5.2.11 Kentucky
9.5.2.12 Oklahoma
9.5.2.13 Virginia
9.5.2.14 Maryland
9.5.2.15 West Virginia
9.6 Midwest Region
9.6.1 Regional Overview & Trends
9.6.2 Midwest Market Size & Forecast, By State
9.6.2.1 Illinois
9.6.2.2 Ohio
9.6.2.3 Michigan
9.6.2.4 Minnesota
9.6.2.5 Indiana
9.6.2.6 Wisconsin
9.6.2.7 Missouri
9.6.2.8 Iowa
9.6.2.9 Kansas
9.6.2.10 Nebraska
9.6.2.11 North Dakota
9.6.2.12 South Dakota
What this section provides: Detailed state-level and regional insights identifying high-growth clusters and infrastructure-driven demand pockets.

10. US Cardiac Monitoring Devices Market: Competitive Landscape & Company Profiles

10.1 Market Share Analysis (2025)
10.2 Company Positioning Matrix
10.3 Company Profiles
10.3.1 Medtronic plc
10.3.2 Abbott Laboratories
10.3.3 Boston Scientific Corporation
10.3.4 GE HealthCare
10.3.5 Koninklijke Philips N.V.
10.3.6 iRhythm Technologies
10.3.7 BioTelemetry (Philips)
10.3.8 Biotronik
10.3.9 ZOLL Medical Corporation
10.3.10 Nihon Kohden America
10.3.11 Baxter International (Hillrom)
10.3.12 AliveCor
10.3.13 Cardiac Insight
10.3.14 Preventice Solutions
10.3.15 Masimo Corporation
10.3.16 Schiller Americas
10.3.17 Spacelabs Healthcare
10.3.18 Bittium Corporation
10.3.19 MicroPort CRM
10.3.20 Garmin Health
10.3.21 Withings
10.3.22 Lepu Medical
10.3.23 VectraCor
10.3.24 Other Emerging Players
What this section provides: Competitive benchmarking, innovation positioning, partnership landscape, and strategic expansion overview.

11. US Cardiac Monitoring Devices Market: Future Market Outlook (2025–2035)

11.1 Scenario Analysis (Optimistic, Realistic, Pessimistic)
11.2 Disruptive Technologies Impact
11.3 Emerging Business Trends
11.4 Opportunities for Startups & Established Players
What this section provides: Long-term forecast modeling and strategic growth trajectory assessment.

12. US Cardiac Monitoring Devices Market: Strategic Recommendations

What this section provides: Actionable strategies for manufacturers, investors, and healthcare providers.

13. US Cardiac Monitoring Devices Market: Disclaimer

What this section provides: Legal, data usage, and limitation disclosures governing the report.

List of Tables

TABLE 1: List of Data Sources
TABLE 2: Market Drivers; Impact Analysis
TABLE 3: Market Restraints; Impact Analysis
TABLE 4: US Cardiac Monitoring Devices Market: Product Type Snapshot (2025)
TABLE 5: Segment Dashboard; Definition and Scope, by Product Type
TABLE 6: US Cardiac Monitoring Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 7: US Cardiac Monitoring Devices Market: Modality Snapshot (2025)
TABLE 8: Segment Dashboard; Definition and Scope, by Modality
TABLE 9: US Cardiac Monitoring Devices Market, by Modality, 2022–2035 (USD Million)
TABLE 10: US Cardiac Monitoring Devices Market: Application Snapshot (2025)
TABLE 11: Segment Dashboard; Definition and Scope, by Application
TABLE 12: US Cardiac Monitoring Devices Market, by Application, 2022–2035 (USD Million)
TABLE 13: US Cardiac Monitoring Devices Market: End-User Snapshot (2025)
TABLE 14: Segment Dashboard; Definition and Scope, by End-User
TABLE 15: US Cardiac Monitoring Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 16: US Cardiac Monitoring Devices Market: Regional Snapshot (2025)
TABLE 17: Segment Dashboard; Definition and Scope, by Region
TABLE 18: US Cardiac Monitoring Devices Market, by Region, 2022–2035 (USD Million)
TABLE 19: California Cardiac Monitoring Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 20: California Cardiac Monitoring Devices Market, by Modality, 2022–2035 (USD Million)
TABLE 21: California Cardiac Monitoring Devices Market, by Application, 2022–2035 (USD Million)
TABLE 22: California Cardiac Monitoring Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 23: Washington Cardiac Monitoring Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 24: Washington Cardiac Monitoring Devices Market, by Modality, 2022–2035 (USD Million)
TABLE 25: Washington Cardiac Monitoring Devices Market, by Application, 2022–2035 (USD Million)
TABLE 26: Washington Cardiac Monitoring Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 27: Colorado Cardiac Monitoring Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 28: Colorado Cardiac Monitoring Devices Market, by Modality, 2022–2035 (USD Million)
TABLE 29: Colorado Cardiac Monitoring Devices Market, by Application, 2022–2035 (USD Million)
TABLE 30: Colorado Cardiac Monitoring Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 31: Arizona Cardiac Monitoring Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 32: Arizona Cardiac Monitoring Devices Market, by Modality, 2022–2035 (USD Million)
TABLE 33: Arizona Cardiac Monitoring Devices Market, by Application, 2022–2035 (USD Million)
TABLE 34: Arizona Cardiac Monitoring Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 35: Oregon Cardiac Monitoring Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 36: Oregon Cardiac Monitoring Devices Market, by Modality, 2022–2035 (USD Million)
TABLE 37: Oregon Cardiac Monitoring Devices Market, by Application, 2022–2035 (USD Million)
TABLE 38: Oregon Cardiac Monitoring Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 39: West – Others Cardiac Monitoring Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 40: West – Others Cardiac Monitoring Devices Market, by Modality, 2022–2035 (USD Million)
TABLE 41: West – Others Cardiac Monitoring Devices Market, by Application, 2022–2035 (USD Million)
TABLE 42: West – Others Cardiac Monitoring Devices Market, by End-User, 2022–2035 (USD Million)
(Nevada, Utah, New Mexico, Idaho, Montana, Wyoming, Alaska, Hawaii)
TABLE 43: New York Cardiac Monitoring Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 44: New York Cardiac Monitoring Devices Market, by Modality, 2022–2035 (USD Million)
TABLE 45: New York Cardiac Monitoring Devices Market, by Application, 2022–2035 (USD Million)
TABLE 46: New York Cardiac Monitoring Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 47: Massachusetts Cardiac Monitoring Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 48: Massachusetts Cardiac Monitoring Devices Market, by Modality, 2022–2035 (USD Million)
TABLE 49: Massachusetts Cardiac Monitoring Devices Market, by Application, 2022–2035 (USD Million)
TABLE 50: Massachusetts Cardiac Monitoring Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 51: New Jersey Cardiac Monitoring Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 52: New Jersey Cardiac Monitoring Devices Market, by Modality, 2022–2035 (USD Million)
TABLE 53: New Jersey Cardiac Monitoring Devices Market, by Application, 2022–2035 (USD Million)
TABLE 54: New Jersey Cardiac Monitoring Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 55: Pennsylvania Cardiac Monitoring Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 56: Pennsylvania Cardiac Monitoring Devices Market, by Modality, 2022–2035 (USD Million)
TABLE 57: Pennsylvania Cardiac Monitoring Devices Market, by Application, 2022–2035 (USD Million)
TABLE 58: Pennsylvania Cardiac Monitoring Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 59: Connecticut Cardiac Monitoring Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 60: Connecticut Cardiac Monitoring Devices Market, by Modality, 2022–2035 (USD Million)
TABLE 61: Connecticut Cardiac Monitoring Devices Market, by Application, 2022–2035 (USD Million)
TABLE 62: Connecticut Cardiac Monitoring Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 63: Northeast – Others Cardiac Monitoring Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 64: Northeast – Others Cardiac Monitoring Devices Market, by Modality, 2022–2035 (USD Million)
TABLE 65: Northeast – Others Cardiac Monitoring Devices Market, by Application, 2022–2035 (USD Million)
TABLE 66: Northeast – Others Cardiac Monitoring Devices Market, by End-User, 2022–2035 (USD Million)
(Maine, Vermont, New Hampshire, Rhode Island, Delaware)
TABLE 67: Texas Cardiac Monitoring Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 68: Texas Cardiac Monitoring Devices Market, by Modality, 2022–2035 (USD Million)
TABLE 69: Texas Cardiac Monitoring Devices Market, by Application, 2022–2035 (USD Million)
TABLE 70: Texas Cardiac Monitoring Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 71: Florida Cardiac Monitoring Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 72: Florida Cardiac Monitoring Devices Market, by Modality, 2022–2035 (USD Million)
TABLE 73: Florida Cardiac Monitoring Devices Market, by Application, 2022–2035 (USD Million)
TABLE 74: Florida Cardiac Monitoring Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 75: Georgia Cardiac Monitoring Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 76: Georgia Cardiac Monitoring Devices Market, by Modality, 2022–2035 (USD Million)
TABLE 77: Georgia Cardiac Monitoring Devices Market, by Application, 2022–2035 (USD Million)
TABLE 78: Georgia Cardiac Monitoring Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 79: North Carolina Cardiac Monitoring Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 80: North Carolina Cardiac Monitoring Devices Market, by Modality, 2022–2035 (USD Million)
TABLE 81: North Carolina Cardiac Monitoring Devices Market, by Application, 2022–2035 (USD Million)
TABLE 82: North Carolina Cardiac Monitoring Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 83: Tennessee Cardiac Monitoring Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 84: Tennessee Cardiac Monitoring Devices Market, by Modality, 2022–2035 (USD Million)
TABLE 85: Tennessee Cardiac Monitoring Devices Market, by Application, 2022–2035 (USD Million)
TABLE 86: Tennessee Cardiac Monitoring Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 87: South Carolina Cardiac Monitoring Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 88: South Carolina Cardiac Monitoring Devices Market, by Modality, 2022–2035 (USD Million)
TABLE 89: South Carolina Cardiac Monitoring Devices Market, by Application, 2022–2035 (USD Million)
TABLE 90: South Carolina Cardiac Monitoring Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 91: Alabama Cardiac Monitoring Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 92: Alabama Cardiac Monitoring Devices Market, by Modality, 2022–2035 (USD Million)
TABLE 93: Alabama Cardiac Monitoring Devices Market, by Application, 2022–2035 (USD Million)
TABLE 94: Alabama Cardiac Monitoring Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 95: South – Others Cardiac Monitoring Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 96: South – Others Cardiac Monitoring Devices Market, by Modality, 2022–2035 (USD Million)
TABLE 97: South – Others Cardiac Monitoring Devices Market, by Application, 2022–2035 (USD Million)
TABLE 98: South – Others Cardiac Monitoring Devices Market, by End-User, 2022–2035 (USD Million)
(Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma, Virginia, Maryland, West Virginia)
TABLE 99: Illinois Cardiac Monitoring Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 100: Illinois Cardiac Monitoring Devices Market, by Modality, 2022–2035 (USD Million)
TABLE 101: Illinois Cardiac Monitoring Devices Market, by Application, 2022–2035 (USD Million)
TABLE 102: Illinois Cardiac Monitoring Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 103: Ohio Cardiac Monitoring Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 104: Ohio Cardiac Monitoring Devices Market, by Modality, 2022–2035 (USD Million)
TABLE 105: Ohio Cardiac Monitoring Devices Market, by Application, 2022–2035 (USD Million)
TABLE 106: Ohio Cardiac Monitoring Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 107: Michigan Cardiac Monitoring Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 108: Michigan Cardiac Monitoring Devices Market, by Modality, 2022–2035 (USD Million)
TABLE 109: Michigan Cardiac Monitoring Devices Market, by Application, 2022–2035 (USD Million)
TABLE 110: Michigan Cardiac Monitoring Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 111: Minnesota Cardiac Monitoring Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 112: Minnesota Cardiac Monitoring Devices Market, by Modality, 2022–2035 (USD Million)
TABLE 113: Minnesota Cardiac Monitoring Devices Market, by Application, 2022–2035 (USD Million)
TABLE 114: Minnesota Cardiac Monitoring Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 115: Indiana Cardiac Monitoring Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 116: Indiana Cardiac Monitoring Devices Market, by Modality, 2022–2035 (USD Million)
TABLE 117: Indiana Cardiac Monitoring Devices Market, by Application, 2022–2035 (USD Million)
TABLE 118: Indiana Cardiac Monitoring Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 119: Wisconsin Cardiac Monitoring Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 120: Wisconsin Cardiac Monitoring Devices Market, by Modality, 2022–2035 (USD Million)
TABLE 121: Wisconsin Cardiac Monitoring Devices Market, by Application, 2022–2035 (USD Million)
TABLE 122: Wisconsin Cardiac Monitoring Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 123: Missouri Cardiac Monitoring Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 124: Missouri Cardiac Monitoring Devices Market, by Modality, 2022–2035 (USD Million)
TABLE 125: Missouri Cardiac Monitoring Devices Market, by Application, 2022–2035 (USD Million)
TABLE 126: Missouri Cardiac Monitoring Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 127: Midwest – Others Cardiac Monitoring Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 128: Midwest – Others Cardiac Monitoring Devices Market, by Modality, 2022–2035 (USD Million)
TABLE 129: Midwest – Others Cardiac Monitoring Devices Market, by Application, 2022–2035 (USD Million)
TABLE 130: Midwest – Others Cardiac Monitoring Devices Market, by End-User, 2022–2035 (USD Million)
(Iowa, Kansas, Nebraska, North Dakota, South Dakota)

List of Figures

FIGURE 1: US Cardiac Monitoring Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Value Chain Analysis
FIGURE 4: PESTLE Analysis
FIGURE 5: Porter’s Five Forces Analysis
FIGURE 6: Market Attractiveness Analysis
FIGURE 7: Market Dynamics
FIGURE 8: Innovation & Patent Landscape (2020–2025)
FIGURE 9: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 10: Product Type Segment Market Share Analysis, 2025 & 2035
FIGURE 11: Product Type Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 12: Modality Segment Market Share Analysis, 2025 & 2035
FIGURE 13: Modality Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 14: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 15: Application Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 16: End-User Segment Market Share Analysis, 2025 & 2035
FIGURE 17: End-User Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 18: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 19: Regional Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 20: West Region Market Share and Leading Players, 2024
FIGURE 21: Northeast Region Market Share and Leading Players, 2024
FIGURE 22: South Region Market Share and Leading Players, 2024
FIGURE 23: Midwest Region Market Share and Leading Players, 2024
FIGURE 24: West Region Market Share Analysis by State, 2024
FIGURE 25: California Cardiac Monitoring Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 26: Washington Cardiac Monitoring Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 27: Colorado Cardiac Monitoring Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 28: Arizona Cardiac Monitoring Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 29: Oregon Cardiac Monitoring Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 30: Others (West Region) Cardiac Monitoring Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 31: South Region Market Share Analysis by State, 2024
FIGURE 32: Texas Cardiac Monitoring Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 33: Florida Cardiac Monitoring Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 34: Georgia Cardiac Monitoring Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 35: North Carolina Cardiac Monitoring Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 36: Tennessee Cardiac Monitoring Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 37: South Carolina Cardiac Monitoring Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 38: Alabama Cardiac Monitoring Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 39: Others (South Region) Cardiac Monitoring Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 40: Midwest Region Market Share Analysis by State, 2024
FIGURE 41: Illinois Cardiac Monitoring Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 42: Ohio Cardiac Monitoring Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 43: Michigan Cardiac Monitoring Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 44: Minnesota Cardiac Monitoring Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 45: Indiana Cardiac Monitoring Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 46: Wisconsin Cardiac Monitoring Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 47: Missouri Cardiac Monitoring Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 48: Others (Midwest Region) Cardiac Monitoring Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 49: Northeast Region Market Share Analysis by State, 2024
FIGURE 50: New York Cardiac Monitoring Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 51: Massachusetts Cardiac Monitoring Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 52: New Jersey Cardiac Monitoring Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 53: Pennsylvania Cardiac Monitoring Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 54: Connecticut Cardiac Monitoring Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 55: Others (Northeast Region) Cardiac Monitoring Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)